Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein

por Zagorski, Karen, Chailyan, Gor, Hovakimyan, Armine, Antonyan, Tatevik, Kiani Shabestari, Sepideh, Petrushina, Irina, Davtyan, Hayk, Cribbs, David H., Blurton-Jones, Mathew, Masliah, Eliezer, Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2022

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease

por Zagorski, Karen, King, Olga, Hovakimyan, Armine, Petrushina, Irina, Antonyan, Tatevik, Chailyan, Gor, Ghazaryan, Manush, Hyrc, Krzysztof L., Chadarevian, Jean Paul, Davtyan, Hayk, Blurton-Jones, Mathew, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2023

Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

por Hovakimyan, Armine, Zagorski, Karen, Chailyan, Gor, Antonyan, Tatevik, Melikyan, Levon, Petrushina, Irina, Batt, Dash G., King, Olga, Ghazaryan, Manush, Donthi, Aashrit, Foose, Caitlynn, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit
Publicado 2022

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

por Davtyan, Hayk, Hovakimyan, Armine, Kiani Shabestari, Sepideh, Antonyan, Tatevik, Coburn, Morgan A., Zagorski, Karen, Chailyan, Gor, Petrushina, Irina, Svystun, Olga, Danhash, Emma, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Blurton-Jones, Mathew, Ghochikyan, Anahit
Publicado 2019

A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

por Hovakimyan, Armine, Antonyan, Tatevik, Shabestari, Sepideh Kiani, Svystun, Olga, Chailyan, Gor, Coburn, Morgan A., Carlen-Jones, William, Petrushina, Irina, Chadarevian, Jean Paul, Zagorski, Karen, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit, Davtyan, Hayk
Publicado 2019

Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

por Kim, Changyoun, Hovakimyan, Armine, Zagorski, Karen, Antonyan, Tatevik, Petrushina, Irina, Davtyan, Hayk, Chailyan, Gor, Hasselmann, Jonathan, Iba, Michiyo, Adame, Anthony, Rockenstein, Edward, Szabo, Marcell, Blurton-Jones, Mathew, Cribbs, David H., Ghochikyan, Anahit, Masliah, Eliezer, Agadjanyan, Michael G.
Publicado 2023

Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

por Kim, Changyoun, Hovakimyan, Armine, Zagorski, Karen, Antonyan, Tatevik, Petrushina, Irina, Davtyan, Hayk, Chailyan, Gor, Hasselmann, Jonathan, Iba, Michiyo, Adame, Anthony, Rockenstein, Edward, Szabo, Marcell, Blurton-Jones, Mathew, Cribbs, David H., Ghochikyan, Anahit, Masliah, Eliezer, Agadjanyan, Michael G.
Publicado 2022

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

por Petrushina, Irina, Hovakimyan, Armine, Harahap-Carrillo, Indira S., Davtyan, Hayk, Antonyan, Tatevik, Chailyan, Gor, Kazarian, Konstantin, Antonenko, Maxim, Jullienne, Amandine, Hamer, Mary M., Obenaus, Andre, King, Olga, Zagorski, Karen, Blurton-Jones, Mathew, Cribbs, David H., Lander, Harry, Ghochikyan, Anahit, Agadjanyan, Michael G.
Publicado 2020